Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The investigators will test the central hypothesis that DFO treatment after SAH may improve
cerebrovascular regulation, mitigate ischemic neural injury, and serve as an effective
neuroprotectant against delayed ischemic injury after SAH.